Supply Chain

Four former Food and Drug Administration commissioners are warning lawmakers about the dangers associated with importing cheaper medications from other countries.

Drug companies are spending more money on direct-to-consumer advertising, causing some critics to question whether the strategy is contributing to high drug spending, reports Kaiser Health News in an article relayed by USA Today.

Here are the six latest drugs and medical devices approved by the Food and Drug Administration since March 5.

Medtronic received market clearance from the Food and Drug Administration for its insertable cardiac monitor.

 The Food and Drug Administration on Tuesday approved Merck & Co.'s drug Keytruda for the treatment of blood cancer.

Sen. Ron Wyden, D-Ore., on Wednesday introduced a bill that would require pharmacy benefit managers to disclose financial information surrounding rebates they receive from drug manufacturers, reports Bloomberg.

PTC Therapeutics on Thursday agreed to purchase Marathon Pharmaceuticals' Duchenne muscular dystrophy treatment for about $75 million in cash and $65 million in stock, reports Reuters.

Here are seven articles published by Becker's Hospital Review this past week highlighting critical issues on the minds of supply chain leaders and how medical devices are named, among other topics.

Developing a new name for a medical device is difficult. The process requires much time, patience, resiliency and an open mind, according to Mike Pile, president and creative director of Uppercase Branding.

The Pew Charitable Trusts recently assessed the policies other high-income countries use to manage prescription drug spending.